We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

FDA Issues Social Media Draft Guidance

Nancy M. Parsons

Nancy M. Parsons,

Washington, D.C.

13 January 2014
FDA’s Office of Prescription Drug Promotion (OPDP) announced today that it has issued draft guidance addressing when company use of interactive promotional media constitutes promotional labeling or advertising under the Food, Drug, and Cosmetic Act. In this long-awaited document, OPDP sets forth a proposal for company submission of such materials “at time of first use,” as required by 21 CFR 314.81 and 601.12. Links to the draft guidance and the related Federal Register Notice follow.
FDA Issues Social Media Draft Guidance
Nancy M. Parsons

Nancy M. Parsons,

Washington, D.C.

EMA to Revise Herbal Medicines Guideline

On 1 September 2016, the European Medicines Agency ("EMA") opened for public consultation a Draft revision to its Guideline on the assessment of clinical safety and efficacy in the...

08 September 2016
Loading data